Rigel Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Rigel Pharmaceuticals Inc
CIK #0001034842
EDGAR Form CIK 2011 - 2026
10-K [0001034842]
10-Q [0001034842]
3 [0001034842]
4 [0001034842]
8-K [0001034842]
SC 13G [0001034842]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Rigel Pharmaceuticals Inc [2026-05-15]
Soleus Capital Master Fund LP Rigel Pharmaceuticals Inc [2026-05-07]
State Street Corp Rigel Pharmaceuticals Inc [2026-02-09]
BlackRock Inc Rigel Pharmaceuticals Inc [2025-02-05]
Invesco Ltd Rigel Pharmaceuticals Inc [2024-11-08]
Morgan Stanley Rigel Pharmaceuticals Inc [2024-02-09]
Soleus Capital Master Fund LP Rigel Pharmaceuticals Inc [2023-02-22]
Goldman Sachs Group Inc Rigel Pharmaceuticals Inc [2023-02-14]
Armistice Capital LLC Rigel Pharmaceuticals Inc [2023-02-14]
State Street Corp Rigel Pharmaceuticals Inc [2023-02-06]
View All
Form 3/4/5 Subject 2011 - 2026
Ali-Jackson Kamil
Rigel Pharmaceuticals Inc
Schorno Dean L
Rojkjaer Lisa
Furey Raymond J
Rodriguez Raul R
Santos David A
Wasman Jane
MOOS Walter H
Miller Michael Patrick
Lapointe Anthony Gregg
Hannah Alison L
Frohlich Mark W
Kotzin Brian L
Lyons Gary A
Dummer Wolfgang
Vance Dolly
Goodwin Bradford S
Katkin Keith
Cabatuan Nelson
Lasaga Joseph
Masuda Esteban
Mayer Eldon C III
Markel Stacy
Duliege Anne-Marie
Ringrose Peter S
Maynard Ryan D
Payan Donald G
Sherwin Stephen A
Grossbard Elliott B
Gower James M
BVF Inc/IL
BVF Investments LLC
BVF Partners L P/IL
Lampert Mark N
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Renton Hollings
Investment 10 LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Rigel Pharmaceuticals Inc RIGL
Stock Option (right to buy) · derivative
2026-02-20 Option exercise 4,000 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-20 Option exercise 4,000 $24.00 96,000
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-20 Sell 4,000 $36.36 145,440
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-17 Grant 53,915 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-17 Grant 18,894 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-17 Grant 20,636 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-17 Grant 19,497 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-17 Grant 19,430 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-10 Tax withheld 3,546 $34.62 122,763
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-10 Tax withheld 7,607 $34.62 263,354
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-10 Tax withheld 3,758 $34.62 130,102
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-10 Tax withheld 3,546 $34.62 122,763
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-10 Tax withheld 3,546 $34.62 122,763
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-02 Tax withheld 5,488 $36.01 197,623
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-02 Tax withheld 14,110 $36.01 508,101
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-02 Tax withheld 5,718 $36.01 205,905
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-02-02 Tax withheld 3,968 $36.01 142,888
Rigel Pharmaceuticals Inc RIGL
Stock Option (right to buy) · derivative
2026-02-01 Grant 12,000 $0.00
Rigel Pharmaceuticals Inc RIGL
Employee Stock Option (right to buy) · derivative
2026-01-26 Option exercise 40,000 $0.00
Rigel Pharmaceuticals Inc RIGL
Common Stock
2026-01-26 Tax withheld 35,424 $37.00 1,310,688
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com